DarioHealth Corp. (DRIO)

Market Cap	27.59M
Revenue (ttm)	27.04M
Net Income (ttm)	-30.09M
Shares Out	41.57M
EPS (ttm)	-0.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	255,642
Open	0.720
Previous Close	0.704
Day's Range	0.623 - 0.739
52-Week Range	0.560 - 1.930
Beta	1.42
Analysts	Strong Buy
Price Target	2.00 (+201.84%)
Earnings Date	Mar 10, 2025

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, wh...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 202
• Stock Exchange: NASDAQ
• Ticker Symbol: DRIO
• Website: https://www.dariohealth.com

Financial Performance

In 2024, DarioHealth's revenue was $27.04 million, an increase of 32.86% compared to the previous year's $20.35 million. Losses were -$30.09 million, -45.15% less than in 2023.

Analyst Forecast

According to one analyst, the rating for DRIO stock is "Strong Buy" and the 12-month stock price forecast is $2.0.

Price Target

$2.0

(201.84% upside)

Analyst Consensus: Strong Buy